Telehealth Delivery of Treatment for Sleep Disturbances in Young Children With Autism Spectrum Disorder
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03668873|
Recruitment Status : Recruiting
First Posted : September 13, 2018
Last Update Posted : April 16, 2019
|Condition or disease||Intervention/treatment||Phase|
|Autism Spectrum Disorder Sleep Disturbance||Behavioral: Sleep Parent Training Behavioral: Sleep Parent Education||Not Applicable|
This study will deliver an already initially tested manualized parent training program specially targeting bedtime and sleep disturbances, but delivered via telehealth platform and enhancing the program using live parent coaching at bedtime. Utilizing REDCap automated survey invitations feature, investigators will provide reminders of the intervention recommendations and data collection requirements. In a randomized clinical trial of 90 children with ASD, ages 2 to less than 7 years, a parent training program targeting sleep disturbance (Sleep Parent Training; SPT), will be compared to Sleep Parent Education (SPE). The investigators hypothesize that SPT will be superior in improving child sleep, child daytime functioning as well as parent well-being compared to SPE.
Specific Aims: Aim 1. To evaluate the efficacy of Sleep Parent Training program (SPT) delivered via telehealth for sleep disturbances compared Sleep Parent Educational Program (SPE, time and attention control) also delivered via telehealth in 90 children with ASD (ages >2 to <7 years) with moderate or greater sleep disturbances as measured by the Composite Sleep Index (CSI) of the modified Simonds and Parraga Sleep Questionnaire (MSPSQ).97 Aim 2. To evaluate the impact of SPT on child and parent quality of life (daytime child behavior, parental stress, parent sense of competency, mental health) compared to SPE.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||90 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Telehealth Delivery of Treatment for Sleep Disturbances in Young Children With Autism Spectrum Disorder|
|Actual Study Start Date :||November 1, 2018|
|Estimated Primary Completion Date :||January 1, 2023|
|Estimated Study Completion Date :||January 1, 2023|
Experimental: Sleep Parent Training
The five SPT sessions (each 60-90 minutes in duration) are individually delivered over 10-weeks. In addition to the five sessions, there are three home visits conducted via Express Care Online (HIPAA compliant video-chat). After Session A, session order may be adjusted to address child-specific problems. One-on-one delivery of SPT permits flexibility for child-specific problems within the program.
Behavioral: Sleep Parent Training
SPT provides a comprehensive intervention that teaches parents the basic concepts and practical skills to address an array of sleep problems.
Active Comparator: Sleep Parent Education
SPE consists of five 60-90 minute sessions, delivered individually over 10 weeks. SPE provides useful information to families of young children with ASD and sleep problems. Session A is designed to develop rapport. The sleep hygiene session (Session B) has been modeled from the RUBI manual. The other sessions include a systematic presentation on several relevant topics. An example of a SPE session is provided in the Intervention section. This condition is intended to parallel what would be offered in typical care, but by telehealth, where a parent might be educated about ASD as well as attend an outpatient appointment at a sleep clinic.
Behavioral: Sleep Parent Education
SPE is a structured program intended to mimic competent treatment as usual. Thus, SPE is an accepted treatment and serves as an active comparator that controls for time and attention.
- Improvement in Sleep Disturbances [ Time Frame: Baseline and 10 weeks ]
After 10 weeks of treatment, children whose parents receive SPT will show greater improvement in sleep as evidenced by reduction on the Composite Sleep Index (CSI) of the modified Simonds and Parraga Sleep Questionnaire and will show significantly reduced disruptive behavior on the parent-rated Irritability subscale of the Aberrant Behavior Checklist (ABC) compared to children whose parents receive SPE.
CSI is a 6-item parent-report measure where items are rated 0 to 2 (range 0 to 12) with higher scores reflecting greater sleep problems. Thus, change in an item score of 1 or 2 points reflects a clinically relevant change. ABC is a 58-item parent-report questionnaire with five subscales: Irritability, Social Withdrawal, Stereotyped Behaviors, Hyperactivity, and Inappropriate Speech each item is rated on a Likert scale from 0 (not a problem) to 3 (severe in degree).
- Parental Quality of Life: PSOC [ Time Frame: Baseline and 10 weeks ]
After 10 weeks of treatment, parents enrolled in SPT will report lower levels of stress and higher levels of competency and health as measured by the Parenting Stress Index (PSI), Parenting Sense of Competence (PSOC), and Parent Health Questionnaire (PHQ) compared to parents in SPE.
PSI is is a 36-item parent-completed questionnaire for children 12 years of age and younger and has three scales: 1) Parental Distress; 2) Difficult Child Characteristics; and, 3) Dysfunctional Parent-Child Interaction. A total score of 88 (85th percentile) and above is considered in the clinically significant range for parental stress. PSOC is 17-item scale was developed to assess parental self-efficacy. Each item is answered on a 6-point scale ranging from strongly disagree to strongly agree, PSOC also yields a Total Competence score, with higher scores reflecting higher competence. PHQ is a brief self-report is designed to assess parental mental health.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03668873
|Contact: Destiny Kaznoch, BSfirstname.lastname@example.org|
|Contact: Mallori King, BAemail@example.com|
|United States, Ohio|
|Cleveland Clinic Lerner School for Autism||Recruiting|
|Cleveland, Ohio, United States, 44104|
|Contact: Destiny Kaznoch, BS|
|Principal Investigator:||Cynthia Johnson, PhD||The Cleveland Clinic|